title: Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.
abstract: BACKGROUND
  Prospective data on factors associated with the non-AIDS-defining cancer (NADC) incidence in HIV-infected individuals are limited.
  
  
  METHODS
  We examined the NADC incidence in 3,158 antiretroviral treatment (ART)-naïve subjects after ART initiation in AIDS Clinical Trials Group trials; extended follow-up was available for 2,122 subjects. Poisson regression was used to examine the associations between covariates and incident NADC.
  
  
  RESULTS
  At ART initiation, subjects (median age 37 years) were 40% non-Hispanic whites, and 82% were male; 23% had CD4+ T cell count ≤ 50 cells/mm³ and 25% had CD4 >350 cells/mm³. Median follow-up was 3.8 years. Among 64 incident NADCs, the most common were 8 anal cancers, 8 basal cell carcinomas, 8 Hodgkin's disease, and 6 lung cancers. In univariate models, age, smoking and recent (time-updated) CD4 were associated with incident NADC. There was no association between initial ART drug class (protease inhibitor, nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor) and NADC. After adjusting for age, race and sex: smoking [relative risk = 2.12 (95% CI = 1.1-4.08)] and recent CD4 (≤ 50 cells/mm³: 3.58, 1.22-10.45; 51-200 cells/mm³: 2.54, 1.30-5.0; 201-350 cells/mm³: 2.37, 1.32-4.26 vs. >350 cells/mm³) were associated with NADC.
  
  
  CONCLUSIONS
  Smoking and lower recent CD4 levels, but not initial ART drug class, were associated with NADC. Strategies for maintaining higher CD4 cell counts and successful smoking cessation may reduce the NADC incidence in the HIV-infected population.
authors: Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass., USA.
authors: Supriya
authors: S
authors: Krishnan
authors: Jeffrey T
authors: JT
authors: Schouten
authors: Denise L
authors: DL
authors: Jacobson
authors: Constance A
authors: CA
authors: Benson
authors: Ann C
authors: AC
authors: Collier
authors: Susan L
authors: SL
authors: Koletar
authors: Jorge
authors: J
authors: Santana
authors: Fred R
authors: FR
authors: Sattler
authors: Ronald
authors: R
authors: Mitsuyasu
references: J Infect Dis. 2003 Nov 15;188(10):1444-54
references: 14624369
references: J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22
references: 19770804
references: J Infect Dis. 2003 Sep 1;188(5):625-34
references: 12934177
references: J Clin Oncol. 2009 Feb 20;27(6):884-90
references: 19114688
references: Lancet. 2007 Jul 7;370(9581):59-67
references: 17617273
references: Clin Infect Dis. 2010 May 1;50(9):1316-21
references: 20297953
references: Clin Infect Dis. 2009 Oct 1;49(7):1109-16
references: 19705973
references: Clin Infect Dis. 2009 Mar 1;48(5):633-9
references: 19202627
references: Curr Opin HIV AIDS. 2009 Jan;4(1):27-34
references: 19339937
references: Am J Epidemiol. 1992 Jan 15;135(2):180-9
references: 1311142
references: Ann Intern Med. 2008 May 20;148(10):728-36
references: 18490686
references: Clin Infect Dis. 2010 Oct 15;51(8):957-62
references: 20825305
references: Oncol Rep. 2007 May;17(5):1121-6
references: 17390054
references: J Natl Cancer Inst. 1999 Apr 21;91(8):708-15
references: 10218509
references: J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):203-8
references: 19617846
references: MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
references: 1361652
references: Cancer Biol Ther. 2008 May;7(5):636-7
references: 18421253
references: Environ Mol Mutagen. 2007 Apr-May;48(3-4):283-98
references: 17358026
references: N Engl J Med. 2003 Dec 11;349(24):2293-303
references: 14668455
references: Top HIV Med. 2008 Oct-Nov;16(4):117-21
references: 18838745
references: AIDS Alert. 2010 Apr;25(4):37-40
references: 20556893
references: AIDS. 2009 Jan 2;23(1):41-50
references: 19050385
references: JAMA. 2006 Aug 16;296(7):769-81
references: 16905783
references: Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):638-42
references: 12869403
references: AIDS. 2008 Apr 23;22(7):841-8
references: 18427202
references: HIV Clin Trials. 2008 Jul-Aug;9(4):269-82
references: 18753121
references: BMJ. 2009 Jan 26;338:a3172
references: 19171560
references: Cancer. 2005 Oct 1;104(7):1505-11
references: 16104038
references: AIDS. 2009 May 15;23(8):875-85
references: 19349851
references: J Acquir Immune Defic Syndr. 2010 Sep;55(1):117-27
references: 20622677
references: Curr Opin HIV AIDS. 2009 Jan;4(1):35-41
references: 19343829
references: AIDS. 2007 Sep 12;21(14):1957-63
references: 17721103
references: Am J Epidemiol. 2008 May 1;167(9):1081-9
references: 18321867
references: N Engl J Med. 2003 Dec 11;349(24):2304-15
references: 14668456
references: N Engl J Med. 2004 Apr 29;350(18):1850-61
references: 15115831